The immunological landscape of CCL26High invasive oral squamous cell carcinoma

The immunological landscape of CCL26High invasive oral squamous cell carcinoma

BackgroundOur previous study demonstrated that CCL26 secreted by cancer-associated fibroblasts (CAF) promoted the invasive phenotype of oral squamous cell carcinoma (OSCC), however, more comprehensive clinical expression patterns of CCL26 and its role in immunotherapy remains ambiguous.MethodsCCL26...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lingyun Liu, Shuo Guan, Yizhuo Xue, Yijia He, Liang Ding, Yong Fu, Sheng Chen, Zhiyong Wang, Yi Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	OSCC CCL26 survival prognosis model immune cell immune check points immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2025.1502073/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
by: Nur Fatinazwa Mohd Faizal, et al.
Published: (2025-01-01)

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study
by: Javier García-Corbacho, et al.
Published: (2025-02-01)

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
by: Pengzhou Kong, et al.
Published: (2025-01-01)

CAFs-released exosomal CREB1 promotes cell progression and immune evasion in thyroid cancer via the positive regulation of CCL20
by: Chen Zheng, et al.
Published: (2025-12-01)

“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany
by: Barbara Seliger
Published: (2024-11-01)

PROLIFERATION AND APOPTOSIS IN RAT MODELS OF ORAL SQUAMOUS CELL CARCINOMA INDUCED BY CAPSAICIN EXTRACT NANOPARTICLE GEL
by: Pratiwi Nur Widyaningsih, et al.
Published: (2023-11-01)

Interferon-γ production in response to the cytotoxic T lymphocyte epitope within an antigen incorporated in simian virus 40 virus-like particles
by: Takeharu Watanabe, et al.
Published: (2025-01-01)

Roitt's essential immunology /
by: Delves, Peter J., et al.
Published: (2017)

Intranasal Immunization with DNA Vaccine HA-CCL19/Polyethylenimine/Chitosan Composite Provides Immune Protection Against H7N9 Infection
by: Yuqing Xiang, et al.
Published: (2024-12-01)

Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01)

Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xinyu Zhang, et al.
Published: (2025-01-01)

Comparative efficacy of programmed death ligand 1 inhibition and chemotherapy in advanced gastric or gastroesophageal junction cancer with combined positive score – a meta-analysis
by: Zakari Shaibu, et al.
Published: (2024-10-01)

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis
by: Konstantinos Lallas, et al.
Published: (2025-01-01)

Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II
by: Junjiang Fu, et al.
Published: (2025-01-01)

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
by: Nan Zhang, et al.
Published: (2025-02-01)

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
by: Man Wang, et al.
Published: (2025-01-01)

CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
by: Raanan Greenman, et al.
Published: (2025-01-01)

TOM40 as a prognostic oncogene for oral squamous cell carcinoma prognosis
by: Lifei Deng, et al.
Published: (2025-01-01)

Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors
by: Mei Zhan, et al.
Published: (2025-01-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

Overcoming immune evasion with innovative multi-target approaches for glioblastoma
by: Hai Su, et al.
Published: (2025-01-01)

PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
by: Zhenxiong Zhao, et al.
Published: (2025-01-01)

Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis
by: Ryunosuke Nakagawa, et al.
Published: (2025-02-01)

Editorial: Immunity and pulmonary vascular diseases: challenges, advances and future perspectives
by: Qi Jin, et al.
Published: (2025-02-01)

Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01)

Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
by: Fangzhou He, et al.
Published: (2025-01-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01)

Innate immune cells in vascular lesions: mechanism and significance of diversified immune regulation
by: Jinjing Wu, et al.
Published: (2025-12-01)

Expression pattern of lncRNA H19 in oral squamous cell carcinoma tissues in comparison to normal tissues. A systematic review
by: Ramya Sekar, et al.
Published: (2025-03-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Desmoglein-2 was a novel cancer-associated fibroblasts-related biomarker for oral squamous cell carcinoma
by: Jin Liu, et al.
Published: (2025-01-01)

Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapy
by: Qi-Chao Yang, et al.
Published: (2025-05-01)

CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
by: Felipe Saceanu Leser, et al.
Published: (2025-02-01)

CCL5 Induces a Sarcopenic-like Phenotype via the CCR5 Receptor
by: Francisco Aguirre, et al.
Published: (2025-01-01)

Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy
by: S. J. Luk, et al.
Published: (2024-12-01)

Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)